Vitrolife AB (VITR) - Financials, balance sheet (quarterly)

Market closed

Access this stock data via API

Vitrolife AB

Financials

Balance sheet

Fiscal date	Mar 2025	Dec 2024	Sep 2024	Jun 2024
Total assets	16.6B	17.4B	16.9B	16.9B
Current assets	2.3B	2.4B	2.1B	2.0B
Cash	—	—	—	—
Cash equivalents	—	—	—	—
Cash and cash equivalents	1.1B	1.1B	925M	853M
Other short term investments	—	—	—	—
Accounts receivable	634M	648M	617M	605M
Other receivables	112M	119M	129M	136M
Inventory	413M	422M	403M	373M
Prepaid assets	—	—	—	—
Restricted cash	—	—	—	—
Assets held for sale	—	—	—	—
Hedging assets	—	—	—	—
Other current assets	—	—	-1M	—
Non current assets	14.4B	15.1B	14.8B	14.9B
Properties	—	—	—	—
Land and improvements	—	—	—	—
Machinery furniture equipment	—	—	—	—
Construction in progress	—	—	—	—
Leases	—	—	—	—
Accumulated depreciation	—	—	—	—
Goodwill	23.5B	24.6B	24.0B	24.2B
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	4.1B	4.3B	4.3B	4.4B
Investments and advances	—	—	—	—
Other non current assets	-1M	—	—	-1M
Total liabilities	3.5B	3.8B	3.7B	3.8B
Current liabilities	605M	705M	724M	669M
Accounts payable	149M	203M	190M	167M
Accrued expenses	—	—	—	—
Short term debt	151M	160M	152M	148M
Deferred revenue	—	—	—	—
Tax payable	34M	26M	102M	73M
Pensions	—	—	—	—
Other current liabilities	81M	100M	90M	83M
Non current liabilities	2.9B	3.1B	3.0B	3.1B
Long term provisions	51M	50M	49M	48M
Long term debt	1.8B	1.9B	1.9B	1.9B
Provision for risks and charges	—	—	—	—
Deferred liabilities	989M	1.1B	1.0B	1.0B
Derivative product liabilities	—	—	—	—
Other non current liabilities	60M	65M	53M	54M
Shareholders equity
Common stock	28M	28M	28M	28M
Retained earnings	-1.5B	-1.6B	-1.7B	-1.9B
Other shareholders equity	—	—	—	—
Total shareholders equity	13.1B	13.6B	13.1B	13.1B
Additional paid in capital	13.5B	13.5B	13.5B	13.5B
Treasury stock	—	—	—	—
Minority interest	2M	2M	2M	2M